Rang	Name	Position
1	Mr. Les D. Funtleyder	Interm CEO, CFO, Principal Financial Officer & Director
2	Mr. Corwin Dale Hooks	Chief Commercial Officer
3	Mr. Constantine Chinoporos	COO & Chief Business Officer
4	Ms. Catherine Thorpe	Interim Chief Accounting Officer
5	Ms. Reena Thomas Colacot	Head of Quality
6	Dr. Todd F. Baumgartner M.D., M.P.H.	Chief Regulatory Officer
7	Dr. Evan Prescott Bailey M.D.	Chief Medical Officer
8	Ms. Dottie Caplan	Executive Vice President of Patient Advocacy & Government Affairs.

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	T. Rowe Price Investment Management,Inc.	19,74%	2,93 Mio. USD
2	Vanguard Group Inc	4,17%	0,62 Mio. USD
3	Knoll Capital Management LP	3,97%	0,59 Mio. USD
4	Deltec Asset Management LLC	2,52%	0,38 Mio. USD
5	BlackRock Inc	2,52%	0,38 Mio. USD
6	PNC Financial Services Group Inc	1,90%	0,28 Mio. USD
7	Renaissance Technologies Corp	1,78%	0,26 Mio. USD
8	Pathstone Holdings LLC	1,73%	0,26 Mio. USD
9	Jane Street Group LLC	1,37%	0,20 Mio. USD
10	Franklin Resources Inc	1,31%	0,20 Mio. USD
11	UBS Group AG	1,25%	0,19 Mio. USD
12	Geode Capital Management, LLC	0,98%	0,15 Mio. USD
13	Adage Capital Partners Gp LLC	0,79%	0,12 Mio. USD
14	Millennium Management LLC	0,69%	0,10 Mio. USD
15	Morgan Stanley - Brokerage Accounts	0,47%	0,07 Mio. USD
16	Deutsche Bank AG	0,41%	0,06 Mio. USD
17	Graham Capital Management	0,38%	0,06 Mio. USD
18	State Street Corp	0,34%	0,05 Mio. USD
19	Lynx1 Capital Management, LP	0,27%	0,04 Mio. USD
20	Marshall Wace Asset Management Ltd	0,22%	0,03 Mio. USD